Following news that it expects revenue for Q3 2021 to be at least $8 million, resulting in total revenue for the nine months ended September 30, 2021 of at least $22 million (twice as much as that period, last year),
PyroGenesis Canada Inc. (TSX-V.PYR, Forum) announced this week that it will provide a $9.2 million (CAD) system to destroy perfluoroalkyl and polyfluoroalkyl substances (
PFAs).
Its client is a large operator of public water systems whose name is being kept confidential to avoid competition. The company will provide its plasma-based thermal process equipment for the two-phase project. The first phase will provide pilot testing, while the second is geared toward full fabrication, furbishing and commissioning of a commercial land-based system.
The pilot system will be ready in six months while the full system’s timeline will be determined based on phase one results.
PFAs are man-made chemicals used in aerospace, automotive and construction, among other industries. Products that may contain PFAs include non-stick cookware, stain-resistant coatings, water-resistant clothing, cleaning products, personal care and cosmetics products and any other product that resists grease, water and oil.
The substances are persistent pollutants that affect humans and wildlife but are either not regulated or only recently starting to be regulated.
According to The Agency for Toxic Substances and Disease Registry, studies have shown that PFA exposure may interfere with hormones, increase cholesterol levels, affect the immune system and increase the risk of cancer. A report from the Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey indicates that PFAs are found in the blood of 97-per-cent of Americans.
P. Peter Pascali, CEO and Chair of PyroGenesis, stated,
“PFAs are obviously a waste stream that has to be addressed, and in short order. As such, we are extremely proud to have been selected, in a highly competitive bidding process, to provide our proprietary plasma-based environmental solution to this significant problem facing the world.
The significance of this announcement goes far beyond the announcement itself, as it represents our first commercial land-based system sold outside of the military and has opened up a significant opportunity for our land-based offerings within this segment. Outside the needs of our current client there are many companies facing the same challenge and we fully expect to be providing similar solutions to these entities as well.”
Datametrex AI Ltd. (TSX-V: DM, Forum) subsidiary
Medi-Call MD has launched in-person patient care services in Vancouver.
Medi-Call is an enhanced telemedicine company providing technology-driven e-health and m-health care services. Certified physicians are now able to examine patients via Medi-Call’s mobile app and be dispatched to patients’ residences or places of work to administer additional care.
Patients can also schedule appointments through the app and track a doctor’s journey in real-time. The service, which will eventually expand across the country, aims to make health care accessible to people in rural or isolated communities, as well as to those with limited time, mobility or transportation choices.
Marshall Gunter, Datametrex’s CEO, sat down with Caroline Egan to provide an update on the app.
“Medi-Call is committed to preserving ongoing continuity of care and the highest clinical standards. Patients will have the option of requesting their favourite providers, but if time is of critical importance on a given day, the nearest provider, even if different, will have full access to all their medical history through the safe and secure electronic medical record-keeping system regardless of visit location, even if it is in a different city. So, in essence, a patient’s doctor’s office will for the first time travel with the client throughout Canada.”
Meanwhile, many organizations are struggling to embrace the new work-from-anywhere world. The crux of this issue is ensuring employees can work both seamlessly and securely from any device and any location.
To this end,
BlackBerry Limited (TSX: BB, Forum) announced today a technology integration between
Okta Inc.'s (NASDAQ: OKTA, Forum) Identity Cloud and
BlackBerry Spark unified endpoint management (UEM). The integration of Okta and BlackBerry UEM enables organizations to make the authentication experience frictionless, optimize workforce productivity and maintain the highest security posture. Identity authentication is a foundational component of an organization's zero trust strategy.
BlackBerry UEM, a comprehensive endpoint management solution with industry-leading security, enables employee productivity across an organization's devices, applications, users, and use cases. BlackBerry UEM is used by many of the world's largest organizations, including governments, financial services, healthcare, and more. The solution has the most government certifications in the industry, including FedRAMP, NIAP, DoDIN APL, and NSA CSfC.
HEXO Corp. (TSX: HEXO, Forum) has reported its
financial results for the fourth quarter and fiscal year ended July 31, 2021.
“I am honoured and humbled to join the team as HEXO’s President & CEO,” said Scott Cooper.
“As we review our last fiscal year, I would like to highlight some key achievements. Last fiscal, HEXO achieved its highest net revenue in the company’s history, leads the Canadian cannabis market in four categories and completed three acquisitions, including the transformative Redecan acquisition, propelling the company to the number one market share position in Canadian adult-use recreational cannabis sales,” commented Cooper.
Highlights:
- Closed the Zenabis acquisition on June 1, 2021, offering diversified cultivation facilities, including a state-of-the-art indoor grow facility in Atholville, NB.
- Completed the acquisitions of Redecan and 48North Cannabis Corp.
- Committed to ESG leadership, by offsetting 100% of its 2020 operational carbon emissions and personal emissions for all employees
- Undertook a strategic reorganization, announcing the departure of co-founder and CEO, Sebastien St-Louis and the appointment of Scott Cooper as HEXO’s new President & CEO
- Appointed Valerie Malone as Chief Commercial Officer and Guillaume Jouet as Chief People & Culture Officer
- Net revenue increased 71% quarter-over-quarter and 43% from Q4’20
- Total Q4’21 net revenue increased to $38.7 million from $22.6 million in Q3’21
- Total net revenue for FY21 grew to $123.5 million from $80.6 million in FY20
- Increased market share in several provinces, including Ontario, Alberta and British Colombia, and maintained a top two market share in Quebec
- Cannabis beverage net revenues increased 70% quarter-over-quarter and 161% from fiscal 2020
- Announced the closing of the acquisition of a 50,000 sq. ft. facility in Colorado
Quarter-over-quarter, Hexo’s total gross margin declined to 20% from 22% in Q3 2021.
What the "Buzz"
Our Bullboards have up to 2 Million pageviews a day. Get the inside scoop on conversations around the most significant trends and stock appreciations in our weekly wrap up.
Get "Buzz on the Bullboards" delivered to your inbox every Thursday!
Buzz on the Bullboards | Sign Up Here
Reliq Health Technologies Inc. (TSX-V:RHT, Forum) has provided a
preliminary update on sales for Q1 FY 2022 (quarter ending September 30, 2021).
“We will file our unaudited quarterly financial statements for the quarter ending September 30, 2021 on or before November 29, 2021,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.
“The preliminary sales figures for Q1 FY 2022 show that revenues have almost tripled, exceeding $1.5 million total for the quarter. This is consistent with our guidance to date that the second half of the year will provide significant growth for the company. Our margins continue to improve as we increase the percentage of revenue coming from recurring software & service subscription fees vs hardware.
The company has now sold all of the hardware (medical monitoring devices) that were held in inventory. Going forward we will facilitate hardware purchases for our clients but do not expect to dedicate significant working capital to devices.
The quarter ending September 30, 2021, was Reliq’s first full profitable quarter. We remain on track to achieve a revenue run rate of $2 million per month by the end of December 2021, with target gross margins of 75% and EBITDA margins of 45%. The company will continue to add Care Managers as needed and will also be hiring a Controller to expand our Finance & Accounting team to support the anticipated growth.
FY 2022 is expected to be a period of very rapid growth due to Medicare’s continued expansion of the scope of their virtual care programs, and the increasing reimbursement amounts available to clinicians who use our iUGO Care platform for their at-risk patients. A typical physician practice can generate over $1 Million in new revenue at profit margins of over 75% by implementing iUGO Care while improving patient health outcomes and quality of life. Reliq’s business model benefits all of the stakeholders in the healthcare system – patients, clinicians and payors.”
Canopy Growth Corp. (TSX: WEED, Forum) just rolled out two new product offerings from its Deep Space brand - Limon Splashdown, a lemon-lime flavour that extends the existing 10mg THC-infused beverage offering, and Deep Space XPRESS, the company's first single 10mg THC gummy offering in Canada.
To see these product, click
here.
Suncor Energy Inc. (TSX: SU, Forum) reported its Q3 2021 financial results, noting that the company generated funds from operations of
$2.6 billion (CAD), underpinned by strong results from the Refining & Marketing business and including the significant planned turnaround at Oil Sands Base.
Mark Little, president and chief executive officer added, “Since the start of 2021, we have returned $2.6 billion (CAD) to our shareholders through share repurchases and dividends and have reduced net debt by $3.1 billion (CAD), demonstrating significant progress towards fortifying our balance sheet and meeting our capital allocation targets for the year.”
Crescent Point Energy Corp. (TSX: CPG, Forum) released its operating and financial results for Q3 2021, highlighting more than
$180 million (CAD) of excess cash flow, or over $580 million (CAD) year-to-date, further enhancing balance sheet strength.
Finally, we have
Whitecap Resources Inc. (TSX: WCP, Forum) who reported in its own Q3 2021 financial results. WCP achieved average production in the third quarter of
115,935 boe/d which was 1,935 boe/d higher than its forecast of 114,000 boe/d as both the base production and new well results continue to outperform expectations. The company said it remains disciplined on capital investments with only $135 million invested in the third quarter compared to its forecast of $165 million (CAD).
Record quarterly funds flow was at $294 million (CAD) resulted in discretionary funds flow of $128 million (CAD) after capital investments of $135 million (CAD) and dividends paid to shareholders of $31 million (CAD). Net income of $1.5 billion (CAD) includes an after-tax impairment reversal of $1.4 billion (CAD) due to increases in forward benchmark commodity prices.
We end things off with a look at last week’s investor pulse poll and it appears that a majority of you who responded know how to make money off buying in dips … maybe I can hit one of you up for some advice.
(Click image to vote.)
Looking ahead, we want to know what you think about the future. It’s a tricky subject, given how erratic the markets in Canada and the US have been – record highs one day, deep in the red the next, who knows where we will be tomorrow? I know where I will be next week at least, right here, with the latest on what’s hot on the Stockhouse Bullboards!
For previous editions of Buzz on the Bullboards: click here.
FULL DICSLOSURE: PyroGenesis Canada Inc and Datametrex AI Ltd. are clients of Stockhouse Publishing.